Trial Profile
Randomized, double blind, placebo-controlled study to assess whether the administration of ramelteon could facilitate the discontinuation of zolpidem (Ambien) greater than or equal to 10 mg therapy in subjects with chronic insomnia.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Jun 2013
Price :
$35
*
At a glance
- Drugs Ramelteon (Primary)
- Indications Insomnia
- Focus Therapeutic Use
- Sponsors Takeda Global Research and Development Center
- 30 Jan 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 23 Jan 2009 Actual end date (May 2008) added as reported by ClinicalTrials.gov.
- 23 Jan 2009 Planned number of patients changed from 130 to 135 as reported by ClinicalTrials.gov.